Core Insights - The article highlights the successful completion of a Pre-A round financing of several million RMB by ZhiNuo Technology, a rising player in the synthetic biology field, which will enhance its production capacity, pipeline expansion, team growth, and commercialization efforts [2][3]. Company Overview - ZhiNuo Technology, established in 2020, is a national high-tech enterprise focused on synthetic biology technology, headquartered in Beijing, with R&D centers and production bases in Suzhou and Dongying, Shandong [3]. - The core team comprises interdisciplinary talents from top institutions like Oxford University and Peking University, led by Dr. Zhu Tianze, who has over a decade of experience in saccharochemistry and metabolic flow optimization [3]. Key Technological Highlights - Precision design of metabolic pathways: The company has built a microbial library covering model and non-model strains, combined with high-throughput screening and AI data analysis, which is expected to release an additional 70% efficiency potential [6]. - Rapid industrialization capability: The transition from laboratory trials to 60-ton fermentation production can be achieved in just 3-6 months, significantly shortening the cycle compared to traditional chemical processes [6]. - Multi-domain pipeline layout: ZhiNuo Technology has developed product lines worth billions to tens of billions, focusing on areas such as human milk oligosaccharides (HMOs), microbial pigments, and food-grade functional ingredients, covering industries like dyeing, daily chemicals, human health, and modern agriculture [6].